GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Total Current Assets

CSPC Pharmaceutical Group (HKSE:01093) Total Current Assets : HK$29,253 Mil (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. CSPC Pharmaceutical Group's total current assets for the quarter that ended in Dec. 2023 was HK$29,253 Mil.

CSPC Pharmaceutical Group Total Current Assets Historical Data

The historical data trend for CSPC Pharmaceutical Group's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Total Current Assets Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15,241.30 18,873.71 24,901.38 26,753.31 29,253.06

CSPC Pharmaceutical Group Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,753.31 - 26,668.08 - 29,253.06

CSPC Pharmaceutical Group Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

CSPC Pharmaceutical Group's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=14320.056+11499.996+3433.004+0
=29,253

CSPC Pharmaceutical Group's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets=Cash, Cash Equivalents, Marketable Securities+Total Receivables+Total Inventories+Other Current Assets
=14320.056+11499.996+3433.004+0
=29,253

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

CSPC Pharmaceutical Group  (HKSE:01093) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

CSPC Pharmaceutical Group's Liquidation Value for the quarter that ended in Dec. 2023 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=14320.056-12320.498+0.75 * 6419.632+0.5 * 3433.004
=8,531

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Total Current Assets Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (HKSE:01093) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Total Current Assets
Comparable Companies
HKSE:01666 HKSE:01643 LLY JNJ MRK ABBV LSE:AZN XSWX:NOVN XSWX:ROG AMGN PFE XPAR:SAN LSE:GSK BMY GILD TSE:4568 TSE:4519 SHSE:600276 BIIB XTER:BAYN
Traded in Other Exchanges
CSPCY:USA CHJTF:USA CVG:Germany
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
Website
https://www.cspc.com.hk
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
Executives
Cai Dong Chen 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Ubs Group Ag 2201 Interest of corporation controlled by you
Blackrock, Inc. 2201 Interest of corporation controlled by you
True Ally Holdings Limited 2201 Interest of corporation controlled by you
Gong Cheng Guo Ji You Xian Gong Si 2101 Beneficial owner
Ding Da Ji Tuan You Xian Gong Si 2101 Beneficial owner

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines